✦ LIBER ✦

PEG IFN-α-2a ± lamivudine for HBeAg-positive chronic hepatitis B

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PEG IFN-α-2b effective against HBeAg+ he

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

IFN-α-2b + lamivudine for resistant chro

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 180 KB

ALT and viral load decline during PEG-IF

✍ M.J. ter Borg; B.E. Hansen; G. Bigot; B.L. Haagmans; H.L.A. Janssen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Interferon-α for HBeAg-positive chronic

✍ Antonio Craxı̀; Danilo Di Bona; Calogero Cammà 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Entecavir versus lamivudine for HBeAg po

✍ Pietro Lampertico 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Entecavir for Treatment of Lamivudine-Re

✍ Morris Sherman; Cihan Yurdaydin; Jose Sollano; Marcelo Silva; Yun–Fan Liaw; Janu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 145 KB